AWA
DPLO

Acorn Wealth Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Acorn Wealth Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,495
Closed -$82K – 133
2019
Q1 		$82K Buy
+14,495
New +$150K 0.07% 122
2018
Q3 		– Sell
-6,911
Closed -$177K – 493
2018
Q2 		$177K Sell
6,911
-4,000
-37% -$93.3K 0.15% 120
2018
Q1 		$243K Buy
10,911
+4,000
+58% +$93.3K 0.21% 94
2017
Q4 		$154K Buy
+6,911
New +$136K 0.14% 123

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acorn Wealth Advisors's DPLO Position: Q2 2019 in Review

Acorn Wealth Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 14,495 shares — an estimated $82K sold.

Acorn Wealth Advisors first reported a position in DPLO in Q4 2017 and held it in 4 quarters. The position peaked at $243K in Q1 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Acorn Wealth Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Acorn Wealth Advisors sold 14,495 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $82K.
  • Acorn Wealth Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 4 quarters.
  • Acorn Wealth Advisors's DIPLOMAT PHARMACY, INC. position peaked at $243K in Q1 2018.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Acorn Wealth Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.